House Passes Bill Co-authored by Lipinski to Help Innovative Small Businesses Create Jobs (October 11, 2017)

Today the House passed H.R. 2763, the Small Business Innovation Research (SBIR) Improvements Act of 2017, which contains innovative provisions authored by Congressman Dan Lipinski (IL-3) that will help small businesses grow and create jobs.  The bill reauthorizes and improves the Small Business Innovation Research Program and Small Business Technology Transfer (STTR) Program, which are two of the most important sources of grant funding for American small businesses.  These programs help create jobs by stimulating technological innovation, helping small businesses meet federal agency research and development (R&D) needs, and increasing the commercialization of federal R&D.

“The SBIR and STTR programs have helped countless innovative small businesses grow jobs through American ingenuity,” said Rep. Lipinski.  “This bill will make these programs work even better by providing small businesses with additional tools for bringing innovations to market which will increase economic impact.”

The bill includes language authored by Lipinski to increase the amount of money that grant recipients are allowed to spend on business and technical services like market research, intellectual property protection, or participation in entrepreneurial training programs such as the highly successful Innovation Corps (I-Corps) program.  This helps small businesses, especially start-ups, use their funds where they know they’re needed most, for technical assistance, creative approaches to problem solving, and other types of guidance needed in today’s marketplace.

The reauthorization bill also contains a provision written by Lipinski to expand the highly successful Phase 0 proof-of-concept partnership pilot program, which he helped create at the National Institutes of Health (NIH) in 2011.  This highly successful program provides the earliest funding for researchers exploring the possibility of turning their research into a viable medical product.  After just two years in operation, the three hubs created by the NIH program have filed 30 patent applications, negotiated 14 technology licenses, formed 7 companies, submitted 53 proposals, and have 70 promising technologies in the pipeline.  In H.R. 2763, Lipinski was able to extend the Phase 0 program for another five years at NIH and expand it to the National Science Foundation, NASA, and the Department of Energy.

“Stony Brook University is thrilled to learn of the passage of the SBIR reauthorization bill by the House,” said Dr. Clinton Rubin, SUNY Distinguished Professor and Director of the Center for Biotechnology.  “Not only does this legislation foster small company growth, but by including support for the Phase 0 Concept Centers, it enables the translation of promising basic biomedical science into new therapeutics, diagnostics, and medical devices.  Visionary, bipartisan legislation such as this is a tremendous vehicle to benefit health and society, as well as strengthen our economy.  We are thankful to Congressman Lipinski for his leadership and commitment.  This bill is certain to stimulate job growth, create companies, and help bring the best treatments to those that so desperately need them.”

On the Committee on Science, Space, and Technology, Lipinski is the Ranking Member of the Subcommittee on Research and Technology, and also sits on the Subcommittees on Energy and Space.